MedTrace Logo

Management and Clinical Outcomes of Patients With Severe Mitral Valve Disease Not Suitable for Surgery

NCT02925819 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 500

Last updated 2025-02-13

No results posted yet for this study

Summary

The objective of this study is to collect in a prospective registry all cases of French patients undergoing an assessment for percutaneous treatment of mitral valve disease on a native valve or due to deterioration after surgical valve repair or replacement. In these patients, valvular surgery should be considered contra-indicated or at prohibitive risk. This registry will evaluate the morbidity and mortality up to 24 months for those patients with severe mitral valve disease who are not included in a clinical trial. The association of demographic, clinical, laboratory, echocardiographic variables and treatment options with morbidity and mortality will be evaluated by univariate and multivariate analyses.

Conditions

  • Mitral Valve Disease

Sponsors & Collaborators

  • French Cardiology Society

    lead OTHER

Principal Investigators

  • Jean-François OBADIA · Hospices Civils de Lyon

  • Bernard IUNG · Assistance Publique - Hôpitaux de Paris

  • Patrice GUERIN · Nantes University Hospital

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-10-31
Primary Completion
2026-12-31
Completion
2026-12-31

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02925819 on ClinicalTrials.gov